Medical device cybersecurity risk types are formally classified using the STRIDE model, the framework recognised by the FDA and EU MDCG 2019-16 for identifying threats across the full device lifecycle. Each category in STRIDE maps a distinct attack vector to a potential patient safety consequence, which means a missed threat category is not just a compliance gap. It is a clinical risk. The FDA and EU frameworks require that every identified threat connect explicitly to a hazardous situation and a harm pathway under ISO 14971. Healthcare professionals and administrators who understand these six risk types are better positioned to meet regulatory expectations and protect patients from preventable harm.
1. What are medical device cybersecurity risk types under STRIDE?
The STRIDE model defines six medical device cybersecurity risk types: spoofing, tampering, repudiation, information disclosure, denial of service, and elevation of privilege. Each category targets a different aspect of device integrity, from identity verification to operational availability. The STRIDE and CVSS framework is the accepted standard for structuring threat models in both premarket submissions and post-market surveillance. Understanding the model as a whole is the starting point for any credible security risk assessment in a healthcare environment.
2. Spoofing: when devices and users are not who they claim to be
Spoofing is the impersonation of a legitimate user, device, or system to gain unauthorised access. In a clinical context, this could mean an attacker using stolen credentials to log into an infusion pump management console, or a rogue device masquerading as a trusted sensor on a hospital network. The consequences range from false alarm suppression to incorrect dosage delivery.
Common spoofing scenarios in medical devices include:
- Credential theft targeting nurse workstations connected to device management systems
- Device identity manipulation where a counterfeit peripheral is accepted as trusted
- Session hijacking on unencrypted wireless connections between monitors and central stations
Regulatory guidance requires manufacturers to implement strong authentication controls, including multi-factor authentication and cryptographic device identity verification, as standard mitigations.
Pro Tip: Require certificate-based mutual authentication between networked medical devices and hospital infrastructure. Password-only authentication is no longer sufficient under current FDA premarket expectations.
3. Tampering: unauthorised modification of hardware or software
Tampering involves the unauthorised alteration of a device's software, firmware, or physical hardware. An attacker who tampers with an insulin pump's firmware could change the maximum bolus limit. An attacker who modifies a ventilator's configuration file could alter alarm thresholds silently. These are not hypothetical scenarios. They represent the direct link between cybersecurity and patient harm that regulators now require manufacturers to document explicitly.
Key tampering attack vectors include:
- Malicious firmware updates delivered through unsecured update channels
- Physical access attacks targeting exposed USB or debug ports
- Unauthorised changes to device configuration files stored without integrity protection
The FDA's Secure Product Development Framework and EU MDR both require controls such as secure boot, code signing, and runtime integrity verification to prevent tampering.
Pro Tip: Disable all unused physical ports on medical devices before deployment. A locked-down physical interface removes an entire class of tampering risk that software controls cannot address alone.
4. Repudiation: when you cannot prove what happened
Repudiation is the ability of an actor to deny having performed an action, because the system lacks the evidence to prove otherwise. In a medical device context, this means an audit trail that is incomplete, unsigned, or absent. If a device configuration changes and no log captures who made the change, when, and from which access point, the incident becomes impossible to investigate reliably.
Repudiation risks create serious problems for healthcare administrators:
- Incident investigations stall without reliable, tamper-evident logs
- Regulatory inspections may find audit trail gaps that trigger non-conformance findings
- Liability exposure increases when clinical events cannot be traced to a root cause
The FDA's premarket guidance requires secure logging and audit controls as part of the cybersecurity documentation package. Non-repudiation mechanisms, such as cryptographically signed log entries and centralised log management, are the standard mitigation.
5. Information disclosure: protecting patient data and device telemetry
Information disclosure is the unauthorised exposure of sensitive data, whether in transit, at rest, or through unintended output channels. Medical devices generate and transmit protected health information (PHI), device telemetry, and configuration data. Any of these can become a target. Healthcare was the most targeted sector for ransomware in 2025 according to the FBI's 2026 report, and vendor-side breaches are a growing vector. That statistic reflects how broadly attackers now cast their net across the healthcare supply chain.
Data categories at risk from medical devices include:
- PHI transmitted between devices and electronic health record systems
- Device telemetry streams that reveal patient condition or treatment parameters
- Configuration and calibration data that could be used to plan a targeted attack
The FDA mandates a machine-readable SBOM for all cyber devices since march 29, 2023. An SBOM gives healthcare organisations visibility into every software component in a device, which is the foundation for identifying components with known vulnerabilities that could expose data.
Pro Tip: Map every data flow between your medical devices and hospital network segments. Unencrypted telemetry streams are a common and easily overlooked disclosure risk.
6. Denial of service: when devices stop working under attack
Denial of service (DoS) attacks target device availability. The goal is not to steal data but to prevent the device from functioning. A DoS attack against a patient monitoring system could suppress alarms during a critical event. An attack against an infusion pump network could force manual workarounds that delay treatment. Operational resilience now ranks above data privacy as the dominant concern in healthcare cybersecurity, because the consequences of unavailability are immediate and physical.
DoS scenarios that affect medical devices directly include:
- Network flooding that overwhelms device communication interfaces
- Resource exhaustion attacks that crash device operating systems
- Targeted disruption of wireless protocols used by implantable or wearable devices
The FDA emphasises cyber resilience and requires manufacturers to design fail-safe modes and document recovery procedures. Enterprise resilience strategies for healthcare include network segmentation, redundant communication paths, and tested failover protocols.
Pro Tip: Test your medical device network for DoS resilience annually. Many hospitals discover that devices share network segments with general IT infrastructure, which dramatically increases the attack surface.
7. Elevation of privilege: gaining access you were never granted
Elevation of privilege occurs when an attacker exploits a vulnerability to gain a higher level of system access than their role permits. In a medical device environment, this could mean a low-privilege maintenance account being used to access administrative functions, or a network-connected device being used as a pivot point to reach clinical systems. The result is an attacker with the ability to change safety-critical configurations or disable protective features.
Privilege escalation risks in medical devices include:
- Unpatched operating system vulnerabilities that allow local privilege escalation
- Hardcoded administrative credentials left in device firmware
- Insufficient separation between user roles in device management interfaces
Regulatory requirements for access control under both FDA and EU MDR call for least-privilege design, role-based access control, and continuous monitoring for anomalous access patterns. The cybersecurity maturity model framework provides a structured way to assess how well your access controls are implemented across the device fleet.
8. How to apply STRIDE in a medical device risk assessment
A STRIDE-based risk assessment follows a defined sequence. The process begins with scoping the device and its operating environment, then building data flow diagrams that show every interface, data store, and external connection. Each element in the diagram becomes a target for systematic threat identification across all six STRIDE categories.
The assessment then integrates with ISO 14971 safety risk management. Cybersecurity risk is a safety event under ISO 14971, which means every identified threat must trace to a hazardous situation and a harm pathway. CVSS v4.0 scoring, adapted for clinical impact, provides the severity rating. Controls are mapped to each threat, tested through methods including fuzz testing and penetration testing, and residual risks are formally accepted.
Regulatory submissions must include the SBOM, a vulnerability management plan, and two distinct patch cycle definitions. The FDA's 2026 guidance requires separate patch timelines for routine updates and emergency out-of-cycle patches. Failing to define both explicitly can block market approval. Threat modelling must also extend beyond the device itself to include third-party service providers and hospital IT infrastructure, because the wider ecosystem is part of the attack surface.
Key takeaways
Medical device cybersecurity risks are patient safety risks, and the STRIDE model is the regulatory standard for classifying and managing them across the device lifecycle.
| Point | Details |
|---|---|
| STRIDE is the regulatory standard | FDA and EU MDCG 2019-16 both require STRIDE-based threat modelling for medical device submissions. |
| Each risk type links to patient harm | Every STRIDE category must connect to a hazardous situation and harm pathway under ISO 14971. |
| SBOM is mandatory since march 2023 | All cyber devices require a machine-readable SBOM with no exemptions under current FDA rules. |
| Two patch cycles are legally required | Manufacturers must define separate timelines for routine and emergency patches to meet FDA approval. |
| Operational availability is the priority | Denial of service and tampering risks now pose greater immediate patient harm than data breaches alone. |
The threat landscape has changed. Has your programme kept up?
I have spent years working with healthcare organisations on cybersecurity risk, and the single most consistent gap I see is not technical. It is conceptual. Teams still treat cybersecurity as a data privacy problem. They focus on PHI exposure, HIPAA checklists, and breach notification timelines. Those matter, but they are no longer the front line.
The front line is operational. State-backed groups now target hospitals as a deliberate tactic to cause disruption and patient harm. That is a fundamentally different threat model than a financially motivated ransomware gang. It means your medical devices are not just a compliance concern. They are a strategic target.
What I find most underappreciated is the supply chain dimension. Threat modelling that stops at the device boundary misses the point entirely. The hospital IT infrastructure, the third-party remote service provider, the cloud-based device management platform: all of these are part of the attack surface. Manufacturers and healthcare administrators need to model threats across the full ecosystem, not just the device itself.
My recommendation to healthcare leaders is direct: embed cybersecurity within your patient safety governance, not your IT governance. When a STRIDE threat assessment sits in a safety risk file alongside hazard analysis and clinical risk controls, it gets the clinical scrutiny it deserves. When it sits in an IT ticketing system, it does not.
— Nick - Sr. Executive
How AccountNext-Nexus supports medical device cybersecurity risk management
Healthcare organisations managing complex device fleets need more than periodic assessments. They need continuous visibility.
AccountNext-Nexus delivers 24/7 monitoring and threat detection built for healthcare environments, covering real-time anomaly detection, compliance alignment with FDA and EU MDR requirements, and rapid incident response. The team brings together cybersecurity, IT management, and compliance under one programme, which means your organisation does not manage fragmented tools or disconnected vendors. For healthcare administrators who need to demonstrate regulatory readiness and protect patient safety simultaneously, AccountNext-Nexus provides the depth and continuity that the current threat environment demands.
FAQ
What is the STRIDE model in medical device cybersecurity?
STRIDE is a threat modelling framework that classifies cybersecurity risks into six categories: spoofing, tampering, repudiation, information disclosure, denial of service, and elevation of privilege. The FDA and EU MDCG 2019-16 both recognise it as the standard approach for medical device risk assessments.
How do cybersecurity risks connect to patient safety under ISO 14971?
ISO 14971 requires that every identified cybersecurity threat trace to a hazardous situation and a patient harm pathway. Regulators treat cybersecurity risk as a safety event, not a separate IT concern, and submissions that fail to document this link face rejection.
What is an SBOM and why is it required for medical devices?
A Software Bill of Materials (SBOM) is a machine-readable inventory of every software component in a device. The FDA has required a complete SBOM for all cyber devices since march 29, 2023, with no exemptions, to support vulnerability management and supply chain transparency.
What types of medical device vulnerabilities are most dangerous clinically?
Tampering and denial of service vulnerabilities carry the highest direct clinical risk because they can alter device behaviour or disable device functionality entirely. Spoofing and elevation of privilege are close behind, as both can give attackers control over safety-critical device functions.
How often should healthcare organisations assess medical device cybersecurity risks?
Risk assessments should occur at device procurement, after significant software updates, and at least annually as part of post-market surveillance. The FDA's guidance also requires out-of-cycle reassessment whenever a critical vulnerability is identified in the device or its software components.